Categories

Most recent posts

  XML Feeds

Search

« Study: Earlier Mammograms Benefit Breast Cancer PatientsTax Policy May Delay Individual Mandate Resolution »

FDA Allows Temporary Importation Of Needed Cancer Drugs

02/22/12

  03:58:17 pm, by MedBen5   , 149 words,  
Categories: News, Prescription, Wellness

FDA Allows Temporary Importation Of Needed Cancer Drugs

In order to head off critical cancer drug shortages, The Food and Drug Administration is loosening up its rules regarding the importation of unapproved foreign drugs, Bloomberg reports.

Detroit-based drugmaker Caraco will temporarily import the drug Lipodox from its Mumbai, India-based parent, Sun Pharmaceutical Industries. Lipodox contains the same active ingredient as Doxil, used for treating ovarian cancer and multiple myeloma.

In a statement announcing the action, the FDA said the supply of Lipodox “is expected to end the shortage and fully meet patient needs in the coming weeks.”

The agency has also given expedited approval to APP Pharmaceuticals for a generic form of methotreaxate, used for leukemia and tumors of the breast and lung. The product is expected to become available in March.

Methotreaxate and Doxil are among 220 types of drugs deemed to be in short supply in the U.S. by the American Society of Health-System Pharmacists.

No feedback yet